SpeechPathology.com Phone: 800-242-5183


Therapy Source Career Center - June 2019

Assistive Devices for Stuttering Treatment

Stephen Hood, PhD

March 10, 2003

Share:

Question

I am currently following an adult fluency client through steps to maintain her fluency in various situations that cause her stress. She has been successful with much of the cognitive educational side of our work and her dysfluencies have decreased. What are the pros and cons of assistive fluency devices?

Answer

You have asked an important and controversial question, one that is not easily dealt with in limited space. In my reply, I will attempt to hit some highlights, and then refer you to a very comprehensive source that tries to give a balanced perspective on the pros and the cons of assistive fluency devices.

There are several parts to your question that are potentially important. Clarification of these issues might be helpful in planning strategies to help your client.

(1) First, you indicated that ''disfluencies have decreased.'' I wonder if you are referring to just the frequency of the stuttering, or whether you are also referring to severity: associated effort/tension/struggle, the duration of moments of stuttering, or the type of stuttering-- e.g., silent blocks, hard contacts/tense pauses, or sound, syllable and word repetitions. What about avoidances? Are the disfluencies decreased because the person is postponing or avoiding stuttering by substituting words, paraphrasing and circumlocuting, or not participating in verbal communication in situations of high communicative stress.

(2) Secondary, there is also the issue of Celexa. This may be important, but I cannot tell because I am not sure of the details of why it is being used. Celexa is frequently used to treat depression, but it might make a difference if the depression is ''generalized'' or related more specifically to the stuttering.

(3) Finally, I note your reference to the fact that she might be looking for ''another quick fix.'' There are a number of ''quick-fix'' procedures that may be temporarily successful, but these are a far cry from the more permanent relief that is ultimately desired. ''Quick-Fix'' programs are rarely permanent.

Assistive fluency devices such as Speak Easy, Fluency Master or the Pocket Fluency System can facilitate improved fluency is a number of individuals. These tend to work best for persons whose stuttering is overt and vocalized. They tend not to work as well for persons whose stuttering contains primarily silent blocks. These systems also do not work well when the person is frequently speaking in environments with significant background noise.

Whether intended by the inventor to actually do so, or whether intended as such by the companies that market and produce these devices, they are not ''cures'' for stuttering. When tears streak down Oprah Winfrey's face as she
extols the virtue of a miracle device, this is misleading to the public and has the potential to build unrealistic hope and optimism in folks whom the device may not prove helpful over the long haul. The SpeakEasy is a prosthesis which, while worn, is helpful for some. Long term outcome studies are still being conducted, so we really do not yet know what the user will think about the device after a long period of use.

There are those who sing the praises of fluency enhancing devices. There are others who have tried them and been totally unimpressed.

For a balanced perspective, I encourage you to visit the Stuttering Home Page. Judy Kuster has done a marvelous job in compiling an objective summary of many of the important issues that are involved. An interview with Judy Kuster about her Stuttering Home Page was done by Speech Pathology Online originally in February of 2003 and that interview and its links are still available via this site.

REFERENCE:

http://www.mnsu.edu/comdis/kuster/TherapyWWW/dafjanus.html

 


stephen hood

Stephen Hood, PhD

Stephen Hood, Ph.D. received his masters and doctoral degrees from the University of Wisconsin-Madison. After serving for 20 years and department chair and clinic director at two different universities, he is now back within the ranks of ''regular faculty.'' Dr. Hood is a Fellow of ASHA, a Member of the ASHA SID-4, and in 2000 was selected Speech-Language Pathologist of the Year by the National Stuttering Association. He has published books, book chapters, and articles, primarily in the area of stuttering. He has also edited several books for the Stuttering Foundation of America.


Related Courses

The Ripple Effect of Stuttering: A Community-Based Approach
Presented by Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow, Mary Weidner, PhD, CCC-SLP
Video

Presenters

Craig Coleman, MA, CCC-SLP, BCS-F, ASHA FellowMary Weidner, PhD, CCC-SLP
Course: #9217Level: Intermediate2 Hours
  'Wonderful examples'   Read Reviews
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)

Creating Allies and Developing Advocacy Skills in Stuttering Therapy
Presented by Brooke Leiman Edwards, MA, CCC-SLP, Hope Gerlach, PhD, CCC-SLP
Video

Presenters

Brooke Leiman Edwards, MA, CCC-SLPHope Gerlach, PhD, CCC-SLP
Course: #92232 Hours
  'Wonderful information in involving parents in dysfluency treatment and teaching student's who stutter self-advocacy skills'   Read Reviews
This is Part 3 of a four-part series. This course will focus on specific strategies for involving parents/caregivers in stuttering therapy, and promoting self-advocacy skills among clients who stutter. Through the use of case studies, the speakers will problem-solve obstacles commonly faced by speech-language pathologists when addressing these important aspects of therapy. (Part 1 - Course 9278, Part 2 - Course 9286, Part 4 - Course 9304)

Best Practices for Stuttering Assessment and Treatment Including the Role of Support Groups
Presented by Katie Gore, MA, CCC-SLP, Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow
Video

Presenters

Katie Gore, MA, CCC-SLPCraig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow
Course: #9225Level: Intermediate2 Hours
  'Great information as I start working with a new stuttering client'   Read Reviews
This course is Part 4 in a four-part series. It will provide an overview of stuttering peer support communities and the clinical importance of incorporating community experience into therapy. Current research and practical application questions will address goal writing, SLP roles and responsibilities, and common challenges connecting therapy to the community. Case studies will be shared to highlight assessment and treatment across various age ranges. (Part 1 - Course 9278, Part 2 - Course 9286, Part 3 - Course 9301)

20Q: Early Childhood Stuttering: Less-Direct and More-Direct Treatment
Presented by J. Scott Yaruss, PhD, CCC-SLP, BCS-F, Nina Reardon-Reeves, MS, CCC-SLP, BCS-F
Text

Presenters

J. Scott Yaruss, PhD, CCC-SLP, BCS-FNina Reardon-Reeves, MS, CCC-SLP, BCS-F
Course: #8978Level: Intermediate1 Hour
  'Important topic'   Read Reviews
This course addresses key issues in the treatment of early childhood stuttering, with a focus on less-direct and more-direct treatment approaches. The course will discuss ways that clinicians can draw upon various approaches to develop individualized treatment so that each child’s and family’s individual needs are addressed.

Difficult Conversations in Stuttering Treatment
Presented by Craig Coleman, MA, CCC-SLP, BCS-F
Video

Presenter

Craig Coleman, MA, CCC-SLP, BCS-F
Course: #8731Level: Intermediate1 Hour
  'The situations he presented were great examples of interactions with parents and clients'   Read Reviews
This course will review scenarios that might result in difficult discussions with parents and children in stuttering assessment and treatment. Strategies for building effective therapeutic partnerships will be discussed.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.